Synonyms Diffuse Lymphoma, Diffuse Lymphomas, Diffuse Mixed Cell Lymphoma + [343] |
Introduction Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease. |
Target |
Mechanism RANKL inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. United States |
First Approval Date25 Mar 2025 |
Target |
Mechanism PDL1 inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. China |
First Approval Date25 Dec 2024 |
Target |
Mechanism PDL1 inhibitors [+2] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. United States |
First Approval Date13 Dec 2024 |
Start Date01 Feb 2027 |
Sponsor / Collaborator- |
Start Date01 Aug 2026 |
Sponsor / Collaborator |
Start Date07 Feb 2026 |
Sponsor / Collaborator |